Aubagio (oh-BAH-gee-oh, teriflunomide), the second ORAL option for relapsing forms of multiple sclerosis (MS)

You'll hear about Aubagio (oh-BAH-gee-oh, teriflunomide), the second ORAL option for relapsing forms of multiple sclerosis (MS).

It's not a completely new drug.

It's the active metabolite of leflunomide (Arava, etc)...the immunomodulator used to slow progression of rheumatoid arthritis.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote